Camcevi Evrópusambandið - íslenska - EMA (European Medicines Agency)

camcevi

accord healthcare s.l.u. - leuprorelin mesilate - blöðruhálskirtli - innkirtla meðferð - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Eligard Stungulyfsstofn og leysir, lausn 7,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

eligard stungulyfsstofn og leysir, lausn 7,5 mg

recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 7,5 mg

Eligard Stungulyfsstofn og leysir, lausn 45 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

eligard stungulyfsstofn og leysir, lausn 45 mg

recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 45 mg

Eligard Stungulyfsstofn og leysir, lausn 22,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

eligard stungulyfsstofn og leysir, lausn 22,5 mg

recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 22,5 mg

Genta-Equine Stungulyf, lausn 100 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

genta-equine stungulyf, lausn 100 mg/ml

franklin pharmaceuticals ltd. - gentamicinum súlfat - stungulyf, lausn - 100 mg/ml

Narcostart Stungulyf, lausn 1 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

narcostart stungulyf, lausn 1 mg/ml

le vet b.v.* - medetomidinum hýdróklóríð - stungulyf, lausn - 1 mg/ml

Narcostop Stungulyf, lausn 5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

narcostop stungulyf, lausn 5 mg/ml

le vet b.v.* - atipamezolum hýdróklóríð - stungulyf, lausn - 5 mg/ml